Differential expression of the lncRNA MIR۱۷HG and miR-۱۸a/miR-۲۰a as candidate ncRNA signatures in stage II/III breast cancer and bioinformatic analysis of ncRNA–mRNA regulatory axes

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 27

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-29-11_009

تاریخ نمایه سازی: 22 آبان 1405

چکیده مقاله:

Objective(s): Breast cancer has remained a significant cause of mortality associated with cancer, necessitating a deeper molecular understanding to improve diagnostics and targeted therapies. Noncoding RNAs (ncRNAs) and their regulatory ncRNA–mRNA axes have recently emerged as important modulators of cancer progression and potential tools for earlier detection and more precise stratification of breast cancer. Among them, MIR۱۷HG variants and the precise regulatory axes of miR-۱۸a/miR-۲۰a, and their mechanisms in stage II/III BC, remain elusive. Materials and Methods: This study addresses this critical gap by integrating data from TCGA miRNAseq and RNAseq datasets with experimental qRT-PCR validation on patient tissues. We investigate MIR۱۷HG transcript variants and their associated miRNAs, especially miR-۱۸a and miR-۲۰a, as candidate stage-associated molecules in stage II/III breast cancer. Co-expressed mRNAs were identified through gene co-expression networks (WGCNA). Results: Potential MIR۱۷HG–miR-۱۸a/۲۰a-mRNA regulatory axes were computationally predicted and functionally annotated to elucidate their involvement in cancer-related signaling pathways. Our findings showed that both MIR۱۷HG splice variants were down-regulated, while their associated miRNAs (miR-۱۸a-۵p and miR-۲۰a-۵p) were overexpressed. Based on in silico prediction and functional annotation, we propose three candidate MIR۱۷HG-centred axes: MIR۱۷HG–miR-۲۰a–BTG۳ (linked to RNA degradation), MIR۱۷HG–miR-۱۸a/miR-۲۰a–PARD۶B (Hippo signaling and cell polarity), and MIR۱۷HG–miR-۲۰a–ZNF۳۶۷ (endocytosis-related processes). Conclusion: Together, these data support MIR۱۷HG and its associated miRNAs as candidate stage II/III breast cancer–associated ncRNA signatures and provide a framework for future functional and clinical validation studies.

نویسندگان

- -

Molecular Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran

- -

Department of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran

- -

Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran

- -

Molecular Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran

- -

Rasoul Akram Hospital Clinical Research and Development Center (RCRDC), Iran University of Medical Sciences, Tehran, Iran

- -

Molecular Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :